1. Baraldi, M., and Zeneroli, M. L. (1982). Experimental hepatic encephalopathy: Changes in ?-aminobutyric acid.Science 216: 427?431.
2. Baraldi, M., Zeneroli, M. L., Ventura, E.,et al. (1984a). Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: Reversal by a benzodiazepine antagonist.Clin. Sci. 67: 167?175.
3. Baraldi, M., Zeneroli, M. L., Ventura, E.,et al. (1984b). Port-systemic encephalopathy in dogs: Changes in brain GABA receptors and neurochemial correlates. In Kleinberger, G., Ferenci, P., Riederer, P., and Thaler, H. (eds.),Advances in Hepatic Encephalopathy and Urea Cycle Diseases, S. Karger, Basel, pp. 353?359.
4. Baraldi, M., Pinelli, G., Ricci, P., and Zeneroli, M. L. (1984c). Toxins in hepatic encephalopathy: The role of the synergistic effect of ammonia, mercaptans and short chain fatty acids.Arch. Toxicol. Suppl. 7: 103?105.
5. Bassett, M. L., Mullen, K. D., Skolnick, P., and Jones, E. A. (1985). GABA and benzodiazepine receptor antagonists ameliorate hepatic encephalopathy in a rabbit model of fulminant hepatic failure.Hepatology 5: 1032.